Tadalafil 20 mg to 40 mg Given Every Second Day Is Effective in Secondary Pulmonary Hypertensio

Tadalafil > tadalafil 40mg


These events have been chosen for inclusion either because of their seriousness,

5.6 Prolonged Erection

Cases of sudden decrease or loss of hearing, which may be accompanied by tinnitus and dizziness, have been reported in patients taking tadalafil. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors [see Adverse Reactions (6.2)]. Tadalafil is also marketed for erectile dysfunction. Inform patients taking tadalafil tablets not to take other PDE5 inhibitors. There have been reports of prolonged erections greater than 4 hours and priapism (painful erections greater than 6 hours in duration) for this class of compounds.

Tadalafil strengths

6 ADVERSE REACTIONS The following serious adverse reactions are discussed elsewhere in the labeling:Hypotension [see Warnings and Precautions (5.1)]Visual Loss [see Warnings and Precautions (5.3) and Patient Counseling Information (17)]Hearing loss [see Warnings and Precautions (5.4)]Priapism [see Warnings and Precautions (5.6)]6.1 Clinical Trials ExperienceBecause clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.Tadalafil was administered to 398 patients with PAH during clinical trials worldwide. In trials of tadalafil tablets, a total of 311 and 251 subjects have been treated for at least 182 days and 360 days, respectively. The overall rates of discontinuation because of an adverse event (AE) in the placebo-controlled trial were 9% for tadalafil tablets 40 mg and 15% for placebo. The rates of discontinuation because of AEs, other than those related to worsening of PAH, in patients treated with tadalafil tablets 40 mg was 4% compared to 5% in placebo-treated patients.In the placebo-controlled study, the most common AEs were generally transient and mild to moderate in intensity. Table 1 presents treatment-emergent adverse events reported by greater than or equal to 9% of patients in the tadalafil tablets 40 mg group and occurring more frequently than with placebo.6.2 Postmarketing ExperienceThe following adverse reactions have been identified during post-approval use of tadalafil. reporting frequency, lack of clear alternative causation, or a combination of these factors.

Product Dosage Quantity + Bonus Price
Tadalista Super Active20mg120 + 16 Pills382.15€ 363.95€
Cialis Generic10mg360 + 10 Pills388.49€ 369.99€
Cialis Generic5mg270 + 10 Pills205.81€ 196.01€
Cialis Generic20mg20 Pills54.72€ 52.11€
Cialis Generic60mg90 + 6 Pills196.67€ 187.30€
Cialis Generic60mg60 + 4 Pills145.06€ 138.15€
Cialis Generic5mg30 + 4 Pills53.56€ 51.01€
Cialis Generic10mg30 + 4 Pills63.32€ 60.30€
Cialis Generic40mg30 + 4 Pills74.97€ 71.40€
Cialis Generic2.5mg20 Pills40.73€ 38.79€
Cialis Generic20mg120 + 8 Pills188.15€ 179.19€

Because these reactions are reported voluntarily from a population of uncertain size, it is not

Estimated Cost of Tadalafil

Should signs of pulmonary edema occur when tadalafil tablets are administered, the possibility of associated PVOD should be considered.5.3 Visual LossWhen used to treat erectile dysfunction, non–arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision, including permanent loss of vision, has been reported postmarketing in temporal association with the use of phosphodiesterase type 5 (PDE-5) inhibitors, including tadalafil. Most, but not all, of these patients had underlying anatomic or vascular risk factors for development of NAION, including but not necessarily limited to: low cup to disc ratio (“crowded disc”), age over 50, diabetes, hypertension, coronary artery disease, hyperlipidemia, and smoking. Based on published literature, the annual incidence of NAION is 2.5-11.8 cases per 100,000 in males aged greater than or equal to 50 in the general population. An observational case-crossover study evaluated the risk of NAION when PDE5 inhibitor use, as a class, typical of erectile dysfunction treatment, occurred immediately before NAION onset (within 5 half-lives), compared to PDE5 inhibitor use in a prior time period. The results suggest an tadalafil weekend pill approximate 2-fold increase in the risk of NAION, with a risk estimate of 2.15 (95% CI 1.06, 4.34).

Less Common Tadalafil Side Effects (Occurring in 1 in 100 people)

A similar study reported a consistent result, with a risk estimate of 2.27 (95% CI 0.99, 5.20). Other risk factors for NAION, such as the presence of “crowded” optic disc, may have contributed to the occurrence of NAION in these studies.Patients with known hereditary degenerative retinal disorders, including retinitis pigmentosa, were not included in the clinical trials, and use in these patients is not recommended.5.4 Hearing ImpairmentCases of sudden decrease or loss of hearing, which may be accompanied by tinnitus and dizziness, have been reported in patients taking tadalafil. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors [see Adverse Reactions (6.2)].5.5 Combination with Other PDE5 InhibitorsTadalafil is also marketed for erectile dysfunction. The safety and efficacy of taking tadalafil tablets together with another PDE5 inhibitor has not been studied. Inform patients taking tadalafil tablets not to take other PDE5 inhibitors.5.6 Prolonged ErectionThere have been reports of prolonged erections greater than 4 hours and priapism (painful erections greater than 6 hours in duration) for this class of compounds. always possible to estimate reliably their frequency

Parameter Value Notes
Absorption Rate Rapid, peak in 2 hours Taken with or without food
Half-Life Approx. 17.5 hours Influences dosing frequency
Bioavailability About 80% Amount reaching systemic circulation
Metabolism Liver, mainly via CYP3A4 Affects drug interactions
Excretion Feces (61%), Urine (36%) Metabolites excreted

or establish a causal relationship to drug exposure.

  • Tadalafil 40mg is less common but used in specific therapeutic contexts.
  • The medication may cause side effects such as muscle pain or back pain.
  • Consult a healthcare professional for proper diagnosis and dosage.
  • It is important to disclose all medications and supplements you take.
  • Avoid using Tadalafil 40mg if you are pregnant or breastfeeding.
  • Report any adverse reactions to your healthcare provider promptly.

The list does not include adverse events that are reported from clinical trials

Contraindication Explanation Alternative Actions
Nitrates use Can cause severe hypotension Consult doctor for alternatives
Severe liver impairment Reduced drug clearance Adjust dose or avoid
Recent stroke or heart attack Risk of adverse cardiovascular events Monitor closely
Hypotension Blood pressure too low Treat underlying causes

and that are listed elsewhere in this

4. Strong Global Supply Chain Support

Patients with conditions that might predispose them to priapism (such as sickle cell anemia, multiple myeloma, or leukemia), or in patients with anatomical deformation of the penis (such as angulation, cavernosal fibrosis, or Peyronie’s disease) are at an increased risk. Priapism, if not treated promptly, can result in irreversible damage to the erectile tissue. Patients who have an erection lasting greater than 4 hours, whether painful or not, should seek emergency medical attention. Tadalafil tablets has vasodilatory properties that may result in transient decreases in blood pressure. Patients with preexisting hypotension, with autonomic dysfunction, with left ventricular outflow obstruction, may be particularly sensitive to the actions of vasodilators.

QUALITATIVE AND QUANTITATIVE COMPOSITION:

Pulmonary vasodilators may significantly worsen the cardiovascular status of patients with pulmonary veno-occlusive disease (PVOD). Should signs of pulmonary edema occur when tadalafil tablets are administered, the possibility of associated PVOD should be considered. When used to treat erectile dysfunction, non–arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision, including permanent loss of vision, has been reported postmarketing in temporal association with the use of phosphodiesterase type 5 (PDE-5) inhibitors, including tadalafil. Other risk factors for NAION, such as the presence of “crowded” optic disc, may have contributed to the occurrence of NAION in these studies. Patients with known hereditary degenerative retinal disorders, including retinitis pigmentosa, were not included in the clinical trials, and use in these patients is not recommended. section.Cardiovascular and cerebrovascular — Serious cardiovascular events,

Side Effect Frequency Severity Management Tips
Headache Common Mild to moderate Hydrate well, OTC pain relief
Indigestion Common Mild Take with food, avoid spicy meals
Muscle Aches Less common Mild Rest, analgesics
Flushing Common Mild Cool environment, hydration
Nasal Congestion Less common Mild Decongestants if needed

including myocardial infarction, sudden cardiac death,

  • Tadalafil 40mg is sometimes used off-label for other medical conditions.
  • Keep a record of your medication intake and any side effects.
  • Do not share Tadalafil 40mg with others, even if they have similar symptoms.
  • Tadalafil 40mg can be part of a comprehensive ED treatment plan.
  • Follow prescribed dosing strictly to avoid adverse effects.
  • Avoid driving or operating machinery if feeling dizzy after taking Tadalafil 40mg.

stroke, chest pain, palpitations, and tachycardia, have been reported postmarketing in temporal association with

Drug Label Information

Mild or moderate (Child Pugh Class A or B): Because of limited clinical experience in patients with mild to moderate hepatic cirrhosis, consider a starting dose of 20 mg once per day. Severe (Child Pugh Class C): Patients with severe hepatic cirrhosis have not been studied. Avoid use of tadalafil tablets [see Use in Specific Populations (8.7)]. Co-administration of tadalafil tablets in Patients on Ritonavir In patients receiving ritonavir for at least one week, start tadalafil tablets at 20 mg once daily. Co-administration of Ritonavir in Patients on Tadalafil tablets Avoid use of tadalafil tablets during the initiation of ritonavir.

Muscular Dystrophy (Orphan)

4 CONTRAINDICATIONS 4.1 Concomitant Organic NitratesTadalafil tablet is contraindicated in patients who are using any form of organic nitrate, either regularly or intermittently. Do not use nitrates within 48 hours of the last dose of tadalafil tablets. Tadalafil tablets potentiates the hypotensive effect of nitrates. This potentiation is thought to result from the combined effects of nitrates and tadalafil tablets on the nitric oxide/cGMP pathway [see Clinical Pharmacology (12.2)].4.2 Concomitant Guanylate Cyclase (GC) StimulatorsCoadministration of GC stimulator such as riociguat with tadalafil tablets is contraindicated. Tadalafil tablets may potentiate the hypotensive effects of GC stimulators.4.3 Hypersensitivity ReactionsTadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil (tadalafil tablets or CIALIS). the use of tadalafil [see Contraindications (4.1)].

Administration Instructions for Tadalafil

Hypersensitivity reactions have been reported, including Stevens-Johnson syndrome and exfoliative dermatitis [see Adverse Reactions (6.2)]. Tadalafil tablet is contraindicated in patients who are using any form of organic nitrate, either regularly or intermittently. This potentiation is thought to result from the combined effects of nitrates and tadalafil tablets on the nitric oxide/cGMP pathway [see Clinical Pharmacology (12.2)]. Coadministration of GC stimulator such as riociguat with tadalafil tablets is contraindicated. Tadalafil tablets may potentiate the hypotensive effects of GC stimulators.

Side effects of taking Tadalafil 40mg Tablets

Tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil (tadalafil tablets or CIALIS). 5 WARNINGS AND PRECAUTIONS 5.1 HypotensionTadalafil tablets has vasodilatory properties that may result in transient decreases in blood pressure. Prior to prescribing tadalafil tablets, carefully consider whether patients with underlying cardiovascular disease could be affected adversely by such vasodilatory effects. Patients with preexisting hypotension, with autonomic dysfunction, with left ventricular outflow obstruction, may be particularly sensitive to the actions of vasodilators.5.2 Worsening Pulmonary Vascular Occlusive DiseasePulmonary vasodilators may significantly worsen the cardiovascular status of patients with pulmonary veno-occlusive disease (PVOD). Since there are no clinical data on administration of tadalafil tablets to patients with veno-occlusive disease, administration of tadalafil tablets to such patients is not recommended.